Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RS2289487 variation in PERILIPIN gene is a predictor of weight loss and protection against impaired glucose metabolism after a meal-replacement diet in postmenopausal obese females.

European review for medical and pharmacological sciences·2023
Same author

Interaction of the variant in the adiponectin gene rs3774261 with serum lipid profile and adiponectin levels after 9 months with a high monounsaturated fat hypocaloric diet with Mediterranean pattern.

European review for medical and pharmacological sciences·2023
Same author

FTO variant RS 1121980 interact with metabolic response after weight loss with a meal replacement hypocaloric diet in Caucasian obese subjects.

European review for medical and pharmacological sciences·2023
Same author

Cholesteryl ester transfer protein rs5833 genetic variant affect HDL-cholesterol levels and ratio total cholesterol/HDL-cholesterol in postmenopausal obese female patient.

European review for medical and pharmacological sciences·2021
Same author

Brain derived neurotrophic factor (BDNF) polymorphism rs 10767664 affects metabolic parameters after weight loss secondary to high fat hypocaloric diet with Mediterranean pattern.

European review for medical and pharmacological sciences·2021
Same author

The lactase rs4988235 is associated with obesity related variables and diabetes mellitus in menopausal obese females.

European review for medical and pharmacological sciences·2021
Same journal

[Giant cell arteritis: and uncommon cause of chronic cough].

Anales de medicina interna (Madrid, Spain : 1984)·2009
Same journal

[Pneumonia and lumbar spondylodiscitis as complications of Staphylococcus aureus's bacteriemia].

Anales de medicina interna (Madrid, Spain : 1984)·2009
Same journal

[Review of eleven cases of erythema induratum at a second level hospital].

Anales de medicina interna (Madrid, Spain : 1984)·2009
Same journal

[Primary bacteremias caused by Pasteurella multocida].

Anales de medicina interna (Madrid, Spain : 1984)·2009
Same journal

[Primary pulmonary lymphoma: an infrequent cause of pulmonary mass].

Anales de medicina interna (Madrid, Spain : 1984)·2009
Same journal

[Drugs and serotonin syndrome].

Anales de medicina interna (Madrid, Spain : 1984)·2009
See all related articles

Related Experiment Videos

[Garlic and cardiovascular risk].

D A de Luis1, R Aller

  • 1Sección de Endocrinología y Nutrición Clínica, Unidad de Apoyo a la Investigación, Hospital Universitario del Río Hortega, Valladolid, Spain. dadluis@yahoo.es

Anales De Medicina Interna (Madrid, Spain : 1984)
|September 5, 2008
PubMed
Summary
This summary is machine-generated.

Garlic consumption shows potential cardiovascular benefits by lowering cholesterol and triglyceride levels. Further research is needed to confirm its impact on cardiovascular events and optimal dosage.

Related Experiment Videos

Area of Science:

  • Nutritional Science
  • Cardiovascular Health

Context:

  • Garlic is a widely consumed dietary vegetable with a long history.
  • Cardiovascular diseases remain a leading cause of mortality globally.
  • Understanding dietary influences on cardiovascular risk factors is crucial.

Purpose:

  • To review the evidence linking garlic consumption to cardiovascular risk factors.
  • To analyze garlic's influence on lipid levels, vascular endothelium, and platelet aggregation.

Summary:

  • Regular intake of raw garlic (5g twice daily for 42 days) reduced cholesterol and triglyceride levels in some studies.
  • Animal models suggest a dose-dependent hypotensive effect of garlic.
  • Garlic consumption demonstrated activation of fibrinolysis, downregulation of coagulation, and inhibition of platelet aggregation.

Impact:

  • Garlic exhibits significant effects on key cardiovascular risk factors.
  • More extensive studies are required to establish a reduction in cardiovascular events and determine optimal garlic intake for health benefits.